Part I: Immunotherapy
Against Amyloid-b in
Alzheimer’s Disease
1. Immunotherapy Against Amyloid-β in Alzheimer’s Disease: An Overview
Niels D. Prins
2. Active Immunization Against the
Amyloid-β Peptide
Enchi Liu
and J. Michael Ryan
3. Immunotherapy
Against N-Truncated Amyloid-β Oligomers
Thomas A.
Bayer and Oliver Wirths
4. Immunotherapy
Against Amyloid-β Protofibrils: Opportunities and Challenges
Lars
Lannfelt
Part II:
Immunotherapy in Other Neurodegenerative Disorders
5. Immunotherapy
Against α-Synuclein Pathology
Elvira
Valera and Eliezer Masliah
6. Extracellular α-Synuclein as a Target for
Immunotherapy
Jun Sung Lee and Seung-Jae Lee
7. Immunotherapy of Parkinson’s Disease
Achim Schneeberger,
Suzanne Hendrix, and Markus Mandler
8. Tau Immunotherapy
Einar M. Sigurdsson
9. Active and Passive Immunotherapy Against Tau: Effects and
Potential Mechanisms
Kiran Yanamandra, Marc
I. Diamond, and David M. Holtzman
10. Immunotherapy on Experimental Models for
Huntington’s Disease
Anne Messer
Part III: Biomarkers for Neurodegenerative Disorders
11. Cerebrospinal Fluid Biomarkers in Alzheimer’s Disease
Henrik Zetterberg and
Jonathan M. Schott
12. Volumetric MRI as a Diagnostic Tool in
Alzheimer's Disease
Eric Westman, Lena Cavalin, and
Lars-Olof Wahlund
13. PET Imaging as a Diagnostic Tool in Alzheimer´s
Disease
Juha O. Rinne
14. Αlpha-Synuclein as a Diagnostic
Biomarker for Parkinson’s Disease
Joakim Bergström and Martin Ingelsson
15. Imaging as a Diagnostic Tool in
Parkinson’s Disease
Johan Wikström and Torsten Danfors
16. Mass
Spectrometry-Based Proteomics
in Biomarker Discovery for Neurodegenerative
Diseases
Sravani Musunuri,
Ganna Shevchenko, and Jonas Bergquist
This practical volume examines a number of topics that explore the current status of immunotherapy and diagnostic markers for neurodegenerative disorders. With a focus on Alzheimer’s disease, the first sections of the book examine immunotherapeutic approaches for the aforementioned disease as well as for Parkinson’s disease and Huntington’s disease, amongst others. The last section of the book covers the importance of biomarker techniques to catch these diseases early enough for the treatments to be most useful. Written for the Methods in Pharmacology and Toxicology series, this book contains the kind of detailed descriptions and implementation advice that will offer a smooth transition into the lab.
Authoritative and useful, Immunotherapy and Biomarkers in Neurodegenerative Disorders aims to aid in the continued progress in the development of novel immune-based drugs and diagnostic tools for these devastating brain diseases.